All In Biotech

Free tool

FAERS Monitor: Camptosar

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 020571 or its brand name (Camptosar, Irinotecan Hydrochloride). Reports on generic versions are filed under their own applications.

Reports

11,125

Serious

10,272

92% of reports

Hospitalization

4,488

Death reported

2,058

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • diarrhoea1,417
  • off label use884
  • nausea810
  • vomiting713
  • myelosuppression697
  • death681
  • disease progression575
  • febrile neutropenia575
  • neutropenia545
  • fatigue487
  • pyrexia443
  • neuropathy peripheral432
  • abdominal pain399
  • asthenia395
  • neoplasm progression371

Reports by year received

View as table
YearReports
2004391
2005171
2006151
2007171
2008271
2009309
2010411
2011395
2012576
2013356
2014239
2015444
2016332
2017344
2018425
2019474
2020544
2021544
2022856
2023858
20241,044
20251,106
2026713

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,043,034 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
myelosuppressionSignal69737.334.724,144
neoplasm progressionSignal37120.418.46,758
febrile neutropeniaSignal57516.515.38,324
disease progressionSignal5759.28.54,213
neuropathy peripheralSignal4328.67.92,903
neutropeniaSignal5457.67.03,127
diarrhoeaSignal1,4174.24.03,494
abdominal painSignal3993.22.9624
vomitingSignal7132.92.7885
pyrexiaSignal4432.42.2374
asthenia3952.01.8196
nausea8101.91.8379
off label use8841.91.8398
death6811.51.4116
fatigue4871.21.114

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.